Literature DB >> 7818283

Point mutations and allelic loss in the TP53 locus of cutaneous malignant melanomas.

J Weiss1, W K Cavenee, R A Herbst, E G Jung, K C Arden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7818283     DOI： 10.1007/bf00371803

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  14 in total

1.  Mutagenic specificity of ultraviolet light.

Authors:  J H Miller
Journal:  J Mol Biol       Date:  1985-03-05       Impact factor: 5.469

Review 2.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

Review 3.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

4.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

5.  Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism.

Authors:  M H Jones; Y Nakamura
Journal:  Genes Chromosomes Cancer       Date:  1992-07       Impact factor: 5.006

Review 6.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

7.  p53 mutations in breast cancer.

Authors:  C Coles; A Condie; U Chetty; C M Steel; H J Evans; J Prosser
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

8.  Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.

Authors:  E Campo; O de la Calle-Martin; R Miquel; A Palacin; M Romero; V Fabregat; J Vives; A Cardesa; J Yague
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

9.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

10.  Mutation and expression of the p53 gene in malignant melanoma cell lines.

Authors:  J Weiss; K Schwechheimer; W K Cavenee; M Herlyn; K C Arden
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396
View more
  1 in total

1.  Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells.

Authors:  Gai Yan; Mark S Eller; Courtney Elm; Cecilia A Larocca; Byungwoo Ryu; Izabela P Panova; Beverley M Dancy; Erin M Bowers; David Meyers; Lisa Lareau; Philip A Cole; Sean D Taverna; Rhoda M Alani
Journal:  J Invest Dermatol       Date:  2013-04-18       Impact factor: 8.551
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.